Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00489567
Status:
COMPLETED
Last Update Posted:
2011-01-31
First Post:
2007-06-20
Brief Title:
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE Its Complications and Diversity of Co-circulating Rotavirus Strains in Children 5 Years of Age in Sweden
Status:
COMPLETED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to estimate the burden of RV GE The study will focus on children hospitalized for severe RV GE Children acquiring RV GE in the hospital and the household contacts of children hospitalized with RV GE It is expected to enrol 500-600 subjects in the study The Protocol Posting has been updated in order to comply with the FDA Amendment Act Sep 2007
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None